Doctors Note Logo

Ubie mascot holding a Q&A card

Your Health Questions
Answered by Professionals

Get expert advice from current physicians on your health concerns, treatment options, and effective management strategies.

Need answers about current symptoms?

Common Questions

Q

Still Depressed? The New Clinical Protocols to Augment Antidepressants

When an antidepressant isn't working well enough, evidence-based augmentation strategies can help. FDA-approved options include atypical antipsychotics like aripiprazole, brexpiprazole, and quetiapine XR, along with lithium, thyroid hormone T3, bupropion, and, in select cases, stimulants. Adding structured psychotherapy also improves outcomes. Before adding a medication, confirm the right dose, adequate duration, and adherence, and rule out medical or substance-related contributors. After two adequate medication trials, treatments like TMS, ECT, or esketamine may be appropriate next steps. Because depression symptoms overlap with many other conditions—thyroid issues, sleep disorders, anxiety, or medication side effects—understanding what's actually driving your symptoms is the critical first step before adjusting treatment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what may be going on, identify possible contributors, and give you clear, personalized guidance to bring to your next doctor's visit—so you can make the most informed decision about your next steps. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? The New Medical Low Dose Ketamine Infusion Protocol

Low-dose ketamine IV infusions, delivered in a monitored clinical setting, can provide rapid relief for treatment-resistant depression. A typical protocol uses 0.5 mg/kg infused over 40 minutes across a series of six treatments, with some patients transitioning to maintenance sessions as needed. Candidacy, safety, and access vary widely. Benefits, side effects, monitoring requirements, costs, and differences from FDA-approved esketamine (Spravato) all influence whether this option is right for you. Because depression symptoms can stem from many overlapping causes—and treatment paths differ accordingly—understanding what's driving your symptoms is the critical first step. Take a free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what may be going on and get personalized guidance on your next steps. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? The New Medical Protocol for Bipolar Light Therapy

Bright light therapy for bipolar depression now uses a specific medical protocol: 10,000 lux white light at midday, starting at 15 minutes daily and gradually increasing to 45–60 minutes, always paired with a mood stabilizer. Clinical studies show this approach reduces depressive symptoms and improves remission rates without raising the risk of mania. Midday timing is considered safer than morning light because it aligns with circadian rhythms while protecting sleep quality. Key considerations include who should avoid light therapy, how to recognize early hypomanic warning signs, proper device setup, and coordinating treatment with your clinician. This is especially important if you have current hypomania or safety concerns like suicidal thoughts. Because bipolar depression symptoms overlap with many other conditions—and because timing and safety matter—it's worth understanding your specific symptom picture before making treatment decisions. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing and guide your next conversation with a clinician, so you don't waste time guessing. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why a Psychiatry Second Opinion Is Your Vital Next Step

Persistent depression despite treatment often warrants a psychiatry second opinion. A fresh evaluation can confirm or refine your diagnosis, adjust medications or therapy, screen for underlying medical causes (like thyroid disorders or vitamin deficiencies), and open the door to advanced options such as TMS (transcranial magnetic stimulation) or esketamine. A second opinion is especially important if: - Symptoms persist beyond 8–12 weeks of treatment - Your depression is worsening - Your current diagnosis feels mismatched to what you're experiencing - You have thoughts of self-harm (seek urgent care immediately) Because depression symptoms overlap with many conditions—and treatment-resistant depression affects roughly 1 in 3 patients—clarifying what's actually driving your symptoms is the critical first step. Before scheduling another appointment, take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what may be behind your ongoing symptoms and get personalized guidance on next steps. It takes just a few minutes and can help you arrive at your next visit better informed and ready to advocate for the care you need. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Bipolar-Safe Antidepressants Fail & New Medical Steps

Persistent depression while taking bipolar-safe antidepressants usually points to one of four issues: an under-optimized mood stabilizer, mixed or rapid-cycling symptoms, antidepressant-induced instability, or an overlooked condition like thyroid dysfunction, anxiety, or ADHD. Evidence-based next steps include: - **Optimize the mood stabilizer first** (lithium, valproate, or lamotrigine at therapeutic levels) - **Use FDA-approved treatments for bipolar depression**: quetiapine, lurasidone, cariprazine, lumateperone, or the olanzapine-fluoxetine combination - **Consider advanced options** when first-line treatments fail: ketamine or esketamine, ECT, or TMS - **Rule out medical contributors**: thyroid panel, sleep apnea screening, vitamin D, and B12 Because bipolar depression is highly individual and treatment paths differ dramatically based on your specific symptom pattern, guessing your next step can cost months of unnecessary suffering. A free, instant <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's driving your symptoms, identify red flags, and walk into your next appointment with focused questions and a clearer direction — all in under 3 minutes. Reviewed for medical accuracy: 06/23/2026

Q

Still Depressed? Why Clinical Trial Eligibility is Your New Medical Path

When depression doesn't improve with standard therapy or medications, clinical trials may offer access to innovative treatments and close medical monitoring not yet available to the general public. Key factors to consider include trial eligibility and inclusion criteria, the informed consent process, built-in safety oversight, and how to collaborate with your doctor on next steps—especially recognizing when urgent symptoms require immediate care. Not sure if your symptoms point to treatment-resistant depression or something else? Understanding what you're experiencing is the critical first step toward finding the right care path, whether that's a clinical trial, a medication adjustment, or urgent support. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to get personalized insights based on your symptoms and clear guidance on what to do next. Reviewed for medical accuracy: 06/26/2026

Q

Still Depressed? Why Experimental Mental Health Is Your New Clinical Path

When standard therapy and antidepressants haven't worked, several emerging treatments may help people with treatment-resistant depression (TRD) by targeting different brain circuits: - **Ketamine or esketamine (Spravato):** Rapid-acting options for TRD, often showing results within hours to days. - **Transcranial Magnetic Stimulation (TMS):** A non-invasive, FDA-cleared brain stimulation therapy. - **Psychedelic-assisted therapy:** Emerging use of psilocybin or MDMA in controlled clinical settings. - **Other neuromodulation approaches:** Including vagus nerve stimulation (VNS) and deep brain stimulation (DBS) for severe cases. Key factors to weigh include eligibility, safety and side effects, access and insurance coverage, and confirming the right diagnosis and personalized care plan with your clinician. Because depression symptoms can overlap with other conditions—like thyroid disorders, anxiety, or bipolar disorder—getting clarity on what you're actually experiencing is the critical first step before pursuing advanced treatments. A quick, free, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you organize your symptoms, identify possible causes, and walk into your next appointment prepared to ask the right questions about TRD options. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Microdosing vs. Clinical Trials for Depression is Your Next Step

Microdosing vs. clinical trials: what's the difference, and which is safer? Microdosing is largely unregulated, with limited scientific evidence, unpredictable dosing and purity, potential drug interactions, and legal risks. Clinical trials, by contrast, provide medical screening, professional supervision, standardized pharmaceutical-grade treatments, ongoing safety monitoring, and are often available at no cost. Below, we also cover urgent symptoms that require immediate care and how to assess your eligibility for trials—helping you choose the safest next step. Because both paths depend heavily on your current symptoms, health history, and specific goals, understanding what's actually going on in your body is the critical first step. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker"> symptom check</a> to clarify your situation, identify possible causes, and get personalized guidance on the safest next steps—whether that's a clinical trial, a doctor's visit, or urgent care. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why New 2026 Treatments are Your Medical Next Step

Depression treatments in 2026 offer new hope, especially for treatment-resistant or severe symptoms. Emerging options include next-generation ketamine and glutamate modulators, supervised psychedelic-assisted therapy, faster personalized TMS, inflammation- and hormone-focused approaches, and AI-guided digital therapeutics. Key considerations include candidacy criteria, required monitoring, access and cost, and how each option combines with talk therapy. Speak with your clinician and review the full guidance below to choose the safest, most effective path for you. Not sure if your symptoms point to depression or something else? Before booking an appointment or starting a new treatment, it's worth understanding what you may be dealing with. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify your symptoms, identify possible causes, and get personalized guidance on next steps—so your conversation with a clinician is faster, more focused, and more productive. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why New Glutamate-Based Antidepressants in Development are the Clinical Breakthrough You Need.

New glutamate-based antidepressants—ketamine and FDA-approved esketamine—can relieve treatment-resistant depression within hours to days. Unlike SSRIs or SNRIs, they rapidly modulate glutamate pathways and boost brain plasticity, offering hope for patients who haven't responded to traditional options. Key considerations include candidate eligibility, the need for medical supervision, and side effects like dissociation and blood pressure spikes. Emerging next-generation oral drugs and mGluR modulators may soon expand options, and clinicians often combine these treatments with therapy or existing medications for best results. If you're struggling with persistent low mood, fatigue, or symptoms that haven't improved with standard treatment, understanding what you're experiencing is the critical first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and prepare targeted questions for your clinician—so you can confidently explore whether newer therapies like glutamate-based antidepressants may be right for you. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why New Medication Trials Are Your Medically Approved Next Step

Treatment-resistant depression affects millions, but medically supervised depression medication trials offer a validated path forward. These regulated studies provide access to newer therapies, expert monitoring, and treatment options specifically designed for depression that hasn't responded to standard medications. Key factors to weigh include eligibility criteria, potential benefits like access to cutting-edge treatments, and risks such as side effects or possible placebo assignment. It's also important to know how to discuss trial participation with your doctor and recognize when symptoms require urgent care. Before exploring clinical trials, it helps to clearly understand your symptoms and how they're impacting you. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify patterns, assess severity, and prepare informed questions for your healthcare provider—an essential first step toward finding the right next move for your mental health. Reviewed for medical accuracy: 07/10/2026

Q

Still Depressed? Why New Mental Health Research Offers Your Next Steps

Depression is more complex than a simple chemical imbalance. Current mental health research shows it involves brain circuits, inflammation, sleep quality, chronic stress, trauma, hormones, genetics, and social connection—which is why personalized care matters. **What are the next steps for treatment-resistant depression?** - Reassess your diagnosis and rule out medical contributors (thyroid, vitamin deficiencies, sleep apnea) - Adjust or combine therapy and medications - Aggressively treat sleep problems - Support physical health and social connection - Consider newer options like ketamine/esketamine, TMS, or ECT when appropriate Because depression symptoms overlap with many other conditions—and because the right next step depends on what's actually driving your symptoms—guessing can waste months of your life. A free, private, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> takes about 3 minutes, asks the same questions a clinician would, and helps you understand possible causes and which specialist to see next. It's the fastest way to turn uncertainty into a clear action plan. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Psilocybin Therapy is the New Clinical Reset

Psilocybin therapy is a structured, medically supervised treatment that combines one or a few doses of psilocybin with guided preparation and integration sessions. Growing clinical research shows it can produce rapid, and sometimes lasting, relief for major depression and treatment-resistant depression by disrupting rigid patterns of brain activity. Key considerations include careful medical screening, understanding who should avoid this therapy (such as those with certain psychiatric or cardiac conditions), and navigating limited legal access, which varies by state and country. Many more important details that could affect your next healthcare steps are explained below. If you're experiencing persistent low mood, hopelessness, or symptoms that haven't responded to standard treatments, understanding what's driving how you feel is the essential first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> from Ubie Health—developed with physicians—can help you clarify your symptoms, identify possible conditions, and guide you toward the right next steps, whether that means speaking with your doctor or exploring advanced therapies like psilocybin. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Rapid Acting Antidepressants Are the New Medical Path to Relief

Rapid-acting antidepressants such as esketamine (Spravato) and medically supervised ketamine can relieve severe or treatment-resistant depression within hours to days. Unlike traditional SSRIs, which take weeks, these therapies target the brain's glutamate system for faster symptom relief. Key considerations include patient eligibility, in-clinic monitoring requirements, potential side effects (dissociation, elevated blood pressure), and integration with ongoing therapy or medication. These treatments are typically reserved for adults who haven't responded to standard antidepressants, and urgent care is essential if suicidal thoughts intensify. Because depression symptoms overlap with many other conditions—and treatment options depend on your specific presentation—understanding what you're experiencing is the critical first step. A free, instant, <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and guide your conversation with a clinician about whether rapid-acting options may be appropriate for you. It takes just a few minutes and requires no signup—an easy, informed way to take the next step. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Research Study Benefits Are Your New Medical Next Step

If depression hasn't improved with therapy, medication, or lifestyle changes, a mental health research study may be a practical next step. These studies often provide early access to innovative treatments, close medical monitoring, and structured, evidence-based care—frequently at reduced or no cost—while helping advance future treatments. **Key things to know:** - Safety is supported by ethical oversight and informed consent - Eligibility rules, potential side effects, and visit schedules vary - Some studies involve a placebo group - Review all details with your clinician before enrolling - Seek urgent help immediately if you experience suicidal thoughts Before exploring a research study, it's important to understand your current symptoms clearly. A free, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify what may be driving your depression, surface related conditions you may not have considered, and guide your next conversation with a clinician. Taking three minutes now can sharpen your next steps—whether that's a new treatment plan, a second opinion, or evaluating a research study. Reviewed for medical accuracy: 06/23/2026

Q

Still Depressed? Why Standard Care Fails and the New Clinical Trial Path to Relief

Still feeling depressed despite medication and therapy? You're not alone—about one-third of people don't fully respond to their first treatment. Standard care can fall short due to individual biology, slow medication adjustments, limited access to specialists, and partial symptom relief that leaves you struggling. Clinical trials may offer a path forward. They often provide closer monitoring, access to newer or faster-acting treatments, and therapies targeting different biological pathways for a more personalized approach. Benefits, risks, and timing vary by person, so understanding your specific symptoms is a critical first step. Before your next conversation with a clinician, take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what you're experiencing. In just a few minutes, you'll get personalized insights into possible causes and next steps—empowering you to advocate for the right care, whether that's adjusting current treatment or exploring a clinical trial. Reviewed for medical accuracy: 07/02/2026

Q

Still Depressed? Why the Future of Psychiatry is Your New Path to Relief

When depression persists despite therapy or medication, modern psychiatry offers faster, more personalized options. These include pharmacogenomic-guided medications, TMS (transcranial magnetic stimulation), ECT, ketamine and esketamine treatments, AI-supported digital tools, and whole-person care approaches. Psychedelic-assisted therapy is also under active study. Key next steps include confirming your diagnosis, consulting a specialist in treatment-resistant depression, screening for underlying issues like sleep disorders, thyroid dysfunction, or inflammation, reviewing insurance and access, and recognizing when urgent help is needed. Because treatment-resistant depression often overlaps with other treatable conditions, clarifying your specific symptoms is the fastest way to identify the right path forward. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and confidently navigate your next steps. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why the Psychiatric Drug Pipeline Is Your New Medical Path to Relief

Still depressed despite treatment? You're not alone, and new options exist. Beyond traditional serotonin-based antidepressants, the psychiatric drug pipeline now includes rapid-acting treatments like ketamine and esketamine, psychedelic-assisted therapy in clinical trials, neurosteroids, and emerging anti-inflammatory and dopamine-targeted therapies that may help when first-line medications fall short. Key factors to consider include eligibility, safety and medical supervision, insurance coverage and access, and what to discuss with your doctor about clinical trials—since these details directly shape your next steps. Not sure what's driving your symptoms or what to do next? Depression can look different for everyone, and identifying the specific pattern of your symptoms is the first step toward finding the right treatment path. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, uncover possible causes, and prepare you with the right questions before your next doctor's visit—saving time and helping you advocate for care that actually works. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Vagus Nerve Stimulation is the Medically-Proven Next Step

Vagus nerve stimulation (VNS) is an FDA-approved treatment for adults with treatment-resistant depression who have not improved after multiple medications and therapy. A small implanted device delivers gentle electrical pulses to the vagus nerve, offering gradual, long-term symptom relief. Key considerations include: - **Candidacy:** Typically for adults who have failed 4 or more antidepressant treatments. - **Procedure:** Involves outpatient surgery to implant the device, followed by programming sessions. - **Side effects:** Hoarseness, throat discomfort, and cough are most common. - **Comparisons:** VNS differs from ECT, TMS, and ketamine in delivery, speed of effect, and duration of benefit. - **Timeline:** Improvement is gradual, often taking several months to a year. - **Urgent care:** Seek help immediately for suicidal thoughts or worsening symptoms. Because depression symptoms vary widely and treatment-resistant depression can overlap with other conditions, it's important to understand your specific symptom profile before pursuing advanced options like VNS. Taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, identify possible causes, and guide your next steps with a healthcare provider—giving you a clearer, more confident starting point. Reviewed for medical accuracy: 07/10/2026

Q

Still Depressed? Why Your Brain Is Inflamed & New Medical Next Steps

Persistent depression that resists standard treatment may be driven by chronic brain inflammation, which disrupts neurotransmitters, stress regulation, and energy production. This connection is especially likely when depression occurs alongside fatigue, brain fog, chronic pain, gut problems, or autoimmune and metabolic conditions. Ask your clinician about a targeted workup, including CRP, thyroid panel, vitamin D, B12, folate, blood sugar and insulin, and autoimmune screening. Evidence-based next steps include optimizing sleep, following a Mediterranean-style diet rich in omega-3s, exercising regularly, and treating any underlying conditions. Seek urgent help immediately for any self-harm thoughts. Because inflammation-related depression overlaps with many other conditions, identifying your specific symptom pattern is the fastest way to clarify next steps. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's driving your symptoms and what to discuss with your doctor. Reviewed for medical accuracy: 06/24/2026

Q

Still Depressed? Why Your Brain is Ready for New Medical Brain Stimulation

Brain stimulation therapies—including TMS, ECT, and VNS—are FDA-cleared or strongly evidence-based treatments for depression that hasn't responded to therapy, medication, or lifestyle changes. These treatments work by directly targeting the disrupted mood circuits in the brain that underlie treatment-resistant depression. Key factors to discuss with your doctor include safety screening, candidacy criteria, expected results, maintenance plans, emerging options, and warning signs that require urgent care. Because treatment-resistant depression has many overlapping causes and symptoms, identifying the right next step starts with understanding your specific symptom pattern. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, surface possible conditions to discuss with your doctor, and guide you toward the most appropriate care—saving you time and giving you confidence in your next conversation with a clinician. Reviewed for medical accuracy: 06/24/2026

Q

Still Depressed? Why Your Brain Is Resisting & New Spravato Treatment Steps

**Why Am I Still Depressed After Trying Antidepressants?** If antidepressants haven't worked, you may have treatment-resistant depression (TRD). Common causes include glutamate pathway dysfunction, stress-driven brain changes, underlying medical or genetic factors, or an initial misdiagnosis. Identifying the right cause is essential to shaping effective next steps. **What Is Spravato (Esketamine) and How Does It Help?** Spravato is an FDA-approved esketamine nasal spray for eligible adults with treatment-resistant depression. Used alongside an oral antidepressant, it offers rapid-acting relief. Treatment requires clinical evaluation, REMS program enrollment, monitored induction and maintenance sessions, and integration with therapy and lifestyle care. Risks and urgent warning signs are outlined below. **Take the Next Step Toward Clarity** Persistent depression is often complex, and self-diagnosis can delay the right treatment. Because TRD overlaps with other conditions—like bipolar disorder, thyroid issues, or anxiety disorders—understanding your specific symptoms is critical before pursuing options like Spravato. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you assess what may be driving your symptoms and guide your next conversation with a clinician—so you can move forward with confidence rather than guesswork. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain is Resisting Meds & New Medical Next Steps

When two antidepressants fail to work, it may indicate **treatment-resistant depression (TRD)**, a condition affecting roughly 30% of people with major depressive disorder. Persistent symptoms after two adequate trials can stem from: - **Complex brain biology** beyond serotonin, involving glutamate, dopamine, and inflammation - **Missed or overlapping diagnoses** such as bipolar disorder, ADHD, or PTSD - **Medical contributors** like thyroid disease, sleep apnea, or vitamin deficiencies - **Genetic differences** in how your body metabolizes medications (pharmacogenomics) **Effective next steps** include optimizing or augmenting current medications, ketamine or esketamine (Spravato), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), structured psychotherapy such as CBT, and targeted lifestyle changes. Seek urgent care immediately if you feel unsafe. Because TRD has multiple possible causes—and each points to a different treatment path—self-guessing wastes valuable time. A quick, free, and private <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's driving your symptoms, identify overlooked conditions, and match you to the right next steps before your next appointment. It takes only 3 minutes and could meaningfully shorten your path to feeling better. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain Isn't Responding: New Clinical Trial Recruitment Steps

Treatment-resistant depression occurs when standard antidepressants fail to improve symptoms, often due to misdiagnosis, incorrect dosing, coexisting conditions, inflammation, or underlying brain circuitry differences. Identifying the right cause is essential to finding effective relief. New clinical trials now offer access to rapid-acting and glutamate-based medications, brain stimulation therapies, anti-inflammatory treatments, and personalized care plans with structured screening, informed consent, and close monitoring. Talk with your clinician about eligibility and next steps. Because depression can stem from many overlapping causes, understanding your specific symptoms is the critical first step toward the right treatment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, identify possible conditions, and guide your next conversation with a healthcare provider—so you don't waste time on treatments that won't work for you. Reviewed for medical accuracy: 06/26/2026

Q

Still Depressed? Why Your Brain Needs Non-SSRI Meds: New Medical Next Steps

If SSRIs haven't relieved your depression after 6 to 8 weeks, you're not alone—about one-third of people don't fully remit on their first antidepressant. Your brain may respond better to non-SSRI options that target dopamine, norepinephrine, or glutamate. **Non-SSRI alternatives to discuss with your doctor include:** - **SNRIs** (venlafaxine, duloxetine) - **Bupropion** (energizing, weight-neutral) - **Mirtazapine or vortioxetine** - **Tricyclic antidepressants (TCAs)** - **MAOIs** (for treatment-resistant cases) - **Ketamine or esketamine** (rapid-acting) - **Augmentation or combination therapy** paired with psychotherapy Each option has distinct benefits, side effects, and best-fit profiles based on your symptoms and health history. Because matching the right treatment to your specific symptoms is critical, take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's driving your depression and confidently navigate your next steps with your doctor. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain Resists Meds & New Experimental Steps

Still depressed after antidepressants? You may have treatment-resistant depression (TRD), which affects roughly 1 in 3 people on antidepressants. Key factors include brain circuit differences, inflammation, genetics, metabolism, or a missed diagnosis (like bipolar disorder or thyroid issues). Newer, evidence-based options include ketamine or esketamine (Spravato), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), psilocybin-assisted therapy, vagus nerve stimulation (VNS), and augmentation strategies pairing your current med with lithium, atypical antipsychotics, or thyroid hormone. Lifestyle pairing matters too: therapy (CBT, IPT), consistent sleep, regular exercise, and nutrition can meaningfully boost medication response. Because the causes of ongoing depression vary widely — and because symptoms overlap with other conditions — self-guessing wastes time you don't have. A free, private, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> takes about 3 minutes, helps identify what may be driving your symptoms, and gives you a clear list of next steps and questions to bring to your doctor. If you're still struggling, this is the fastest way to move forward with clarity. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain Resists Meds & New Ketamine Medical Steps

When antidepressants don't work, the cause is often more complex than medication choice alone. Factors include brain connectivity and plasticity changes, inflammation, stress hormone overactivity, genetics, misdiagnosis, incorrect dosing, or coexisting conditions—a pattern known as treatment-resistant depression. Ketamine offers a different medical path. By acting on glutamate rather than serotonin, it rapidly rebuilds synaptic communication. Monitored IV infusions and FDA-approved esketamine help 50–70% of patients within hours to days, though maintenance treatment and a comprehensive care plan are typically required. Safety screening, contraindications, and urgent warning signs should always be reviewed with a qualified clinician. Because treatment-resistant depression has many possible drivers, understanding your specific symptoms is the critical first step before choosing a path forward. Taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, identify possible causes, and prepare informed questions for your doctor—so your next conversation leads to answers, not another dead end. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain Resists Meds & New Medically Approved Steps

Why don't antidepressants work for everyone? Up to 1 in 3 people with major depression don't fully respond to their first antidepressant. Common reasons include brain circuit differences, mismatched medication targets, inadequate dose or duration, overlapping conditions or misdiagnosis, unresolved trauma, and genetic differences in how the body metabolizes medication. Medically approved next steps include medication optimization or augmentation, interventional psychiatry such as TMS and esketamine, ECT, evidence-based psychotherapy, and targeted lifestyle support. Each option fits different needs and requires specific safety monitoring, and some situations warrant urgent evaluation. Because treatment-resistant depression has many possible causes, identifying your specific symptom pattern is the critical first step toward finding what will actually work for you. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, surface conditions that may be overlapping or misdiagnosed, and guide your next conversation with a clinician—so you can stop guessing and start moving forward. Reviewed for medical accuracy: 07/09/2026

Q

Still Depressed? Why Your Brain Resists Meds & New Medically Proven Next Steps

Treatment-resistant depression affects up to one-third of people who don't respond to their first antidepressant. If therapy and medications haven't worked, this guide explains why your brain may resist treatment and outlines clear next steps: rechecking your diagnosis, optimizing or switching drug classes, combining therapies, augmentation strategies, and evidence-based options like TMS, ECT, and esketamine. Key factors include medical and lifestyle blockers to test for, a step-by-step roadmap with questions to ask your doctor, and urgent warning signs requiring immediate care. Because treatment-resistant depression has many overlapping causes—from misdiagnosis to hidden medical issues—identifying what's actually driving your symptoms is the critical first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what may be going on and guide your next conversation with your doctor. Reviewed for medical accuracy: 07/10/2026

Q

Still Depressed? Why Your Brain Resists Meds and New Medically-Approved Paths to Experimental Care

When standard antidepressants fail, it's often due to underlying causes like inflammation, glutamate imbalance, circuit dysfunction, genetic variations, or an overlooked co-occurring condition. Treatment-resistant depression has several medically approved next-line options, including esketamine (Spravato), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS) in select cases. Key steps to take: confirm your diagnosis is accurate, document prior medication trials (doses, duration, response), and explore access to experimental depression treatments through clinical trials or expanded access programs. Off-label care may also be appropriate in specific situations and should be discussed with a psychiatrist. Before your next appointment, it's worth understanding what may be driving your symptoms so you can advocate for the right treatment path. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible contributing conditions, clarify what to bring up with your psychiatrist, and navigate your next steps with more confidence — all in just a few minutes. Reviewed for medical accuracy: 07/09/2026

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Not sure about the cause of your current symptoms?

AI Symptom Check

Try our AI-based symptom checker

With an easy 3-min questionnaire, you can get a free AI-powered report on possible causes


Tips to try:

  • Provide specific, detailed info about all symptoms you have.
  • Give accurate information about yourself including current conditions.
  • Answer all follow-up questions

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.